Please find the attached Intimation of Closure of Trading Window for the Second Quarter ended 30th September, 2026

£ “occanto CRE ANTO GLOBAL LIMITED nown as Raymed Labs Limited) Regoff: C- block. Sector 63, Gautam Buddha Nagar. Noida Uttar Pradesh-201301 CIN: 122203 1992PLCO14240 Website: wiww.cresantoglobal.com Email: raymedlabs @rediffinail.com. Phone no 38669898 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai — 400001 Scrip Code — 531207 Sub: Intimation of closure of Trading Window as per SEBI (Prohibition of Insider Trading) Regulations, 2015 for approval of Unaudited Financial Results for the Second quarter ended on 30™ September, 2026 Dear Sir/Madam, As per the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Person and their immediate Relatives of the Company read with SEBI (Prohibition of Insider Trading) Regulations, 2015 Trading window for dealing in securities of the Company will remain closed from Thursday, 01% October, 2026 till completion of 48 hours after Unaudited Financial Results for the second quarter ended 30" September, 2026 generally made available to public. In view of above, all concerned person are advising not to deal (buy or sell) in Securities of Cresanto Global Limited during the said prohibited period. Further, the date of Board Meeting for consideration of the Unaudited financial results of the Company for the second quarter ended 30" September, 2026 will be intimated in due course. This is for your information and records. Thanking you, Yours faithfully, FOR CRESANTO GLOBAL LIMITED (Formerly known as Raymed Labs Limited) Prashant Nathmal Bajaj Managing Director DIN: 06634046 Date: 28" September, 2026 Place: Mumbai Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawala Lane, Goregaon East, Mumbai-400063